76 related articles for article (PubMed ID: 9307579)
1. New insights into the neuropathology and cell biology of Alzheimer's disease.
Weldon DT; Maggio JE; Mantyh PW
Geriatrics; 1997 Sep; 52 Suppl 2():S13-6. PubMed ID: 9307579
[TBL] [Abstract][Full Text] [Related]
2. Macrophage colony stimulatory factor and interferon-gamma trigger distinct mechanisms for augmentation of beta-amyloid-induced microglia-mediated neurotoxicity.
Li M; Pisalyaput K; Galvan M; Tenner AJ
J Neurochem; 2004 Nov; 91(3):623-33. PubMed ID: 15485493
[TBL] [Abstract][Full Text] [Related]
3. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.
Yan SD; Chen X; Fu J; Chen M; Zhu H; Roher A; Slattery T; Zhao L; Nagashima M; Morser J; Migheli A; Nawroth P; Stern D; Schmidt AM
Nature; 1996 Aug; 382(6593):685-91. PubMed ID: 8751438
[TBL] [Abstract][Full Text] [Related]
4. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
[TBL] [Abstract][Full Text] [Related]
5. Possible role of scavenger receptor SRCL in the clearance of amyloid-beta in Alzheimer's disease.
Nakamura K; Ohya W; Funakoshi H; Sakaguchi G; Kato A; Takeda M; Kudo T; Nakamura T
J Neurosci Res; 2006 Sep; 84(4):874-90. PubMed ID: 16868960
[TBL] [Abstract][Full Text] [Related]
6. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
[TBL] [Abstract][Full Text] [Related]
7. Scavenger receptor control of chromogranin A-induced microglial stress and neurotoxic cascades.
Hooper C; Fry VA; Sevastou IG; Pocock JM
FEBS Lett; 2009 Nov; 583(21):3461-6. PubMed ID: 19800883
[TBL] [Abstract][Full Text] [Related]
8. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils.
El Khoury J; Hickman SE; Thomas CA; Cao L; Silverstein SC; Loike JD
Nature; 1996 Aug; 382(6593):716-9. PubMed ID: 8751442
[TBL] [Abstract][Full Text] [Related]
9. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
El Khoury J; Luster AD
Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
[TBL] [Abstract][Full Text] [Related]
11. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
[TBL] [Abstract][Full Text] [Related]
12. The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines.
Chiarini A; Dal Pra I; Whitfield JF; Armato U
Ital J Anat Embryol; 2006; 111(4):221-46. PubMed ID: 17385278
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.
Mohri I; Kadoyama K; Kanekiyo T; Sato Y; Kagitani-Shimono K; Saito Y; Suzuki K; Kudo T; Takeda M; Urade Y; Murayama S; Taniike M
J Neuropathol Exp Neurol; 2007 Jun; 66(6):469-80. PubMed ID: 17549007
[TBL] [Abstract][Full Text] [Related]
14. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.
Kubo T; Nishimura S; Kumagae Y; Kaneko I
J Neurosci Res; 2002 Nov; 70(3):474-83. PubMed ID: 12391608
[TBL] [Abstract][Full Text] [Related]
15. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease.
Nagele RG; Wegiel J; Venkataraman V; Imaki H; Wang KC; Wegiel J
Neurobiol Aging; 2004; 25(5):663-74. PubMed ID: 15172746
[TBL] [Abstract][Full Text] [Related]
16. The role of inflammation in Alzheimer's disease.
Tuppo EE; Arias HR
Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
[TBL] [Abstract][Full Text] [Related]
17. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
[TBL] [Abstract][Full Text] [Related]
18. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
Blasko I; Stampfer-Kountchev M; Robatscher P; Veerhuis R; Eikelenboom P; Grubeck-Loebenstein B
Aging Cell; 2004 Aug; 3(4):169-76. PubMed ID: 15268750
[TBL] [Abstract][Full Text] [Related]
19. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
[TBL] [Abstract][Full Text] [Related]
20. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
